Iris Unito Prodmetadata only
PD-(L)1 containing rechallenge strategies in patients with advanced NSCLC previously treated with immunotherapy: A systematic review and meta-analysis across resistance phenotypes
acquired resistance, docetaxel, immune checkpoint inhibitor resistance, immunotherapy rechallenge, non-small-cell lung cancer, pd-(l)1 inhibitor, primary resistance, second-line therapy
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 320317
Conceptio Open Knowledge Archive — every document is proof-bundled with source, license, and retrieval metadata.